Recurrence of pulmonary veno-occlusive disease after heart-lung transplantation

Gabriel Izbicki, David Shitrit, Itzhak Schechtman, Danielle Bendayan, Gershon Fink, Gideon Sahar, Milton Saute, Tuvia Ben-Gal, Mordechai R. Kramer*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Abstract

Pulmonary veno-occlusive disease, a rare cause of pulmonary hypertension, is characterized by extensive and diffuse occlusion of pulmonary veins by fibrous tissue. Although the diagnosis can be suspected by the presence of the classic clinical triad of severe pulmonary arterial hypertension, radiographic evidence of pulmonary hypertension and edema, and normal pulmonary artery occlusion pressure, the definitive diagnosis is histopathologic. The prognosis of pulmonary veno-occlusive disease is poor with most described patients dying within 2 years of diagnosis. Although anti-coagulation, oxygen, and vasodilator therapies are effective temporarily, the definitive treatment is lung transplantation. We describe the recurrence of pulmonary veno-occlusive disease at 3 months after heart-lung transplantation in a 26-year-old man. Recurrence after transplantation for this disease has not been reported previously, and lung transplantation was thought to be definitive treatment. With this 1st report of early recurrence of pulmonary veno-occlusive disease after heart-lung transplantation, we believe that extrapulmonary factors may play a role in the pathogenesis of this rare disease.

Original languageEnglish
Pages (from-to)635-637
Number of pages3
JournalJournal of Heart and Lung Transplantation
Volume24
Issue number5
DOIs
StatePublished - May 2005

Fingerprint

Dive into the research topics of 'Recurrence of pulmonary veno-occlusive disease after heart-lung transplantation'. Together they form a unique fingerprint.

Cite this